Ekso Bionics Holdings Stock In The News

EKSO Stock  USD 0.62  0.02  2.97%   
Our overall analysis of Ekso Bionics' news coverage and content from conventional and social sources shows investors' bearish mood towards Ekso Bionics Holdings. The specific impact of Ekso Bionics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Ekso Bionics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Ekso Bionics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Ekso Bionics Backtesting and Ekso Bionics Hype Analysis.

Ekso Bionics Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Ekso Bionics to Participate at Centers f...
https://www.globenewswire.com/news-release/2023/11/16/2782242/29945/en/Ekso-Bionics-to-Participate-at-Centers-for-Medicare-Medicaid-Services-CMS-Second-Biannual-2023-Healthcare-Common-Procedure-Coding-System-HCPCS-Public-Meeting-on-Wednesday-November-.html
 Bullish
Macroaxis News: globenewswire.com
Centers for Medicare & Medicaid Services (CMS) Codifies Medicare Coverage for Ekso Indego Personal
https://www.globenewswire.com/news-release/2023/11/02/2772774/29945/en/Centers-for-Medicare-Medicaid-Services-CMS-Codifies-Medicare-Coverage-for-Ekso-Indego-Personal.html
 Bullish
Macroaxis News: globenewswire.com
Ekso Bionics Reports Third Quarter 2023 Revenue Growth of 38%
https://www.globenewswire.com/news-release/2023/10/26/2767972/29945/en/Ekso-Bionics-Reports-Third-Quarter-2023-Revenue-Growth-of-38.html
 Neutral
Macroaxis News: globenewswire.com
Ekso Bionics to Report Third Quarter 2023 Financial Results on October 26, 2023
https://www.globenewswire.com/news-release/2023/10/19/2763666/29945/en/Ekso-Bionics-to-Report-Third-Quarter-2023-Financial-Results-on-October-26-2023.html
 Bullish
Macroaxis News: globenewswire.com
Ekso Bionics Supports Centers for Medica...
https://www.globenewswire.com/news-release/2023/09/27/2750321/29945/en/Ekso-Bionics-Supports-Centers-for-Medicare-Medicaid-Services-CMS-Proposed-Rule-to-Include-Personal-Exoskeletons-within-a-Medicare-Benefit-Category.html
 Bullish
Macroaxis News: globenewswire.com
Ekso Bionics to Participate at the H.C. Wainwright 25th Annual Global Investment Conference
https://www.globenewswire.com/news-release/2023/09/11/2740714/29945/en/Ekso-Bionics-to-Participate-at-the-H-C-Wainwright-25th-Annual-Global-Investment-Conference.html
 Bullish
Macroaxis News: globenewswire.com
Ekso Bionics Reports Record Revenues of $4.7 Million in Second Quarter 2023
https://www.globenewswire.com/news-release/2023/07/27/2712685/29945/en/Ekso-Bionics-Reports-Record-Revenues-of-4-7-Million-in-Second-Quarter-2023.html
 Neutral
Macroaxis News: globenewswire.com
Ekso Bionics to Report Second Quarter 2023 Financial Results on July 27, 2023
https://www.globenewswire.com/news-release/2023/07/20/2708123/29945/en/Ekso-Bionics-to-Report-Second-Quarter-2023-Financial-Results-on-July-27-2023.html
 Bullish
Macroaxis News: globenewswire.com
Ekso Bionics Announces 61% Increase in First Quarter 2023 Revenues
https://www.globenewswire.com/news-release/2023/04/27/2656888/29945/en/Ekso-Bionics-Announces-61-Increase-in-First-Quarter-2023-Revenues.html
 Neutral
Macroaxis News: globenewswire.com
Ekso Bionics to Report First Quarter 2023 Financial Results on April 27, 2023
https://www.globenewswire.com/news-release/2023/04/20/2650917/29945/en/Ekso-Bionics-to-Report-First-Quarter-2023-Financial-Results-on-April-27-2023.html
 Bullish

Ekso Bionics Holdings Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Ekso and other traded companies coverage with news coverage. We help investors stay connected with Ekso headlines for the 23rd of January to make an informed investment decision based on correlating the impacts of news items on Ekso Stock performance. Please note that trading solely based on the Ekso Bionics Holdings hype is not for everyone as timely availability and quick action are needed to avoid losses.
Ekso Bionics' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Ekso Bionics Holdings investors visualize upcoming and past events in order to time the market based on Ekso Bionics Holdings noise-free hype analysis.
Ekso Bionics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Ekso earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Ekso Bionics that are available to investors today. That information is available publicly through Ekso media outlets and privately through word of mouth or via Ekso internal channels. However, regardless of the origin, that massive amount of Ekso data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ekso Bionics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ekso Bionics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ekso Bionics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ekso Bionics alpha.

Ekso Largest EPS Surprises

Earnings surprises can significantly impact Ekso Bionics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-07-27
2023-06-30-0.28-0.31-0.0310 
2024-04-29
2024-03-31-0.16-0.2-0.0425 
2022-04-28
2022-03-31-0.41-0.360.0512 
2021-07-29
2021-06-30-0.25-0.190.0624 
2023-10-26
2023-09-30-0.31-0.240.0722 
2022-11-03
2022-09-30-0.24-0.33-0.0937 
View All Earnings Estimates

Ekso Bionics Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Ekso Bionics Holdings Stock. Current markets are slightly bullish. About 55% of major world exchanges and indexes are currently up. See today's market update for more information.
Yahoo News
20th of December 2024
Neurorehabilitation Market Expected to Reach USD 6.18 Billion by 2032 at a CAGR of 13.68 p...
at finance.yahoo.com 
Yahoo News
25th of November 2024
Rehabilitation Robots Market Analysis Report 2025-2030, Featuring Profiles of Tyromotion, ...
at finance.yahoo.com 
Yahoo News
18th of November 2024
Ekso Bionics to Showcase Its Device Technology in AI for Good Webinar on Tuesday, November...
at finance.yahoo.com 
news
14th of November 2024
StockNews.com Initiates Coverage on Ekso Bionics
at thelincolnianonline.com 
Google News at Macroaxis
11th of November 2024
Ekso Bionics stock hits 52-week low at 0.83 amid market challenges - Investing.com
at news.google.com 
Gurufocus Stories at Macroaxis
29th of October 2024
Ekso Bionics Holdings Inc Q3 2024 Earnings Call Highlights Navigating Challenges with ...
at gurufocus.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ekso Bionics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ekso Bionics' short interest history, or implied volatility extrapolated from Ekso Bionics options trading.
When determining whether Ekso Bionics Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ekso Bionics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ekso Bionics Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ekso Bionics Holdings Stock:
Check out Ekso Bionics Backtesting and Ekso Bionics Hype Analysis.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ekso Bionics. If investors know Ekso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ekso Bionics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.64)
Revenue Per Share
1.004
Quarterly Revenue Growth
(0.10)
Return On Assets
(0.24)
Return On Equity
(0.74)
The market value of Ekso Bionics Holdings is measured differently than its book value, which is the value of Ekso that is recorded on the company's balance sheet. Investors also form their own opinion of Ekso Bionics' value that differs from its market value or its book value, called intrinsic value, which is Ekso Bionics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ekso Bionics' market value can be influenced by many factors that don't directly affect Ekso Bionics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ekso Bionics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ekso Bionics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ekso Bionics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.